Document is current
Any future updates will be listed below
-
Authors
Park, Jong-Sung
Kam, Tae-In
Lee, Saebom
Park, Hyejin
Oh, Yumin
Kwon, Seung-Hwan
Song, Jae-Jin
Kim, Donghoon
Kim, Hyunhee
Jhaldiyal, Aanishaa
Na, Dong Hee
Lee, Kang Choon
Park, Eun Ji
Pomper, Martin G.
Pletnikova, Olga
Troncoso, Juan C.
Ko, Han Seok
Dawson, Valina L.
Dawson, Ted M.
Lee, Seulki
-
Funding
Funding for this research was provided by:
Edward N. and Della L. Thome Memorial Foundation
Maryland Stem Cell Research Fund (2018-MSCRFD-4338)
National Institute of Neurological Disorders and Stroke (NS38377, NS107404)
JPB Foundation
National Research Foundation of Korea
- License Information
-
More Information
Article History
Received: 7 April 2021
Accepted: 10 April 2021
First Online: 26 April 2021
Declarations
:
: J.S.P., K.C.L., E.J.P., and S.L. are employees of D&D Pharmatech. Sa.L., Y.O., S.H.K., and S.L. are employees of Neuraly. M.G.P., H.S.K., V.L.D, T.M.D., and S.L. hold ownership equity of D&D Pharmatech and this arrangement has been reviewed and approved by the Johns Hopkins University in accordance with its conflict of interest policies.
